tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

TG Therapeutics Inc

TGTX
Add to Watchlist
54.860USD
-0.890-1.60%
Close 07-28 16:00（ET）Quotes delayed by 15 min
8.40BMarket Cap
17.14P/E TTM

TG Therapeutics Inc

54.860
-0.890-1.60%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

TGTX Financials

See TG Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

TG Therapeutics Inc Earnings Date

Latest Release
May 6, 2026
EPS / Forecast
0.14/0.29
Revenue / Forecast
204.92M/196.81M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
616.29M
87.32%
EPS(YoY)
3.10
1825.67%
Analyst Rating
BUY
2026/07/28
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
296.87%0.14
3.59%0.17
9952.73%2.69
304.14%0.19
147.11%0.03
259.45%0.16
-96.65%0.03
114.13%0.05
73.81%-0.07
73.93%-0.10
--0.80
---0.34
---0.28
---0.39
---1.08
----
----
----
----
----
Revenue
69.56%204.92M
78.00%192.57M
92.79%161.71M
92.13%141.15M
90.40%120.86M
146.04%108.19M
-49.41%83.88M
357.05%73.47M
713.46%63.47M
54863.75%43.97M
176298.94%165.81M
2606.06%16.07M
287.05%7.80M
-96.55%80.00K
-95.37%94.00K
-61.55%594.00K
154.22%2.02M
6007.89%2.32M
5242.11%2.03M
3965.79%1.54M
Net Profit
290.85%19.78M
-1.26%23.04M
9974.61%390.89M
309.75%28.19M
147.26%5.06M
261.84%23.33M
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.22%-52.99M
58.17%-35.82M
48.39%-40.51M
23.85%-69.01M
-5.80%-93.34M
1.75%-85.64M
-48.43%-78.50M
Net Margin
130.51%9.65%
-44.53%11.96%
5125.74%241.73%
113.27%19.97%
124.82%4.19%
165.78%21.57%
-93.27%4.63%
103.16%9.36%
96.64%-16.87%
99.95%-32.79%
--68.71%
---296.19%
---502.78%
---66242.50%
---5373.05%
----
----
----
----
----
Gross Margin
-4.01%83.65%
-6.50%80.19%
-7.02%82.63%
-2.38%86.58%
-4.69%87.14%
4.42%85.77%
-9.22%88.86%
0.66%88.70%
2.71%91.43%
-14.66%82.14%
--97.88%
--88.11%
--89.02%
--96.25%
--90.31%
----
----
----
----
----
Debt to assets ratio
30.78%48.74%
-45.40%23.10%
-42.55%23.94%
36.46%34.88%
37.31%37.27%
39.29%42.31%
39.46%41.66%
-42.23%25.56%
-44.49%27.14%
-17.34%30.38%
--29.88%
--44.24%
--48.90%
--36.75%
--32.14%
----
----
----
----
----
Income Statement
Revenue
69.56%204.92M
78.00%192.57M
92.79%161.71M
92.13%141.15M
90.40%120.86M
146.04%108.19M
-49.41%83.88M
357.05%73.47M
713.46%63.47M
54863.75%43.97M
176298.94%165.81M
2606.06%16.07M
287.05%7.80M
-96.55%80.00K
-95.37%94.00K
-61.55%594.00K
154.22%2.02M
6007.89%2.32M
5242.11%2.03M
3965.79%1.54M
Operating profit
303.56%34.80M
68.60%50.49M
136.17%29.36M
295.22%34.84M
193.01%8.62M
339.88%29.95M
-89.17%12.43M
119.73%8.82M
74.94%-9.27M
76.02%-12.48M
428.30%114.78M
-14.72%-44.67M
44.68%-36.99M
43.99%-52.06M
58.93%-34.96M
49.75%-38.94M
25.03%-66.87M
-7.10%-92.95M
0.69%-85.13M
-52.41%-77.49M
Net Profit
290.85%19.78M
-1.26%23.04M
9974.61%390.89M
309.75%28.19M
147.26%5.06M
261.84%23.33M
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.22%-52.99M
58.17%-35.82M
48.39%-40.51M
23.85%-69.01M
-5.80%-93.34M
1.75%-85.64M
-48.43%-78.50M
Balance Sheet
Current assets
68.65%1.09B
11.37%630.76M
4.48%599.76M
70.62%663.96M
78.74%644.51M
78.13%566.36M
79.89%574.07M
86.58%389.15M
95.14%360.58M
88.94%317.94M
74.45%319.11M
2.97%208.57M
-23.71%184.78M
-49.16%168.27M
-50.80%182.92M
-55.49%202.56M
-54.73%242.22M
-45.90%330.96M
42.81%371.78M
61.98%455.07M
Total current liabilities
16.79%187.11M
69.57%153.76M
25.33%156.81M
58.18%171.89M
60.72%160.21M
68.80%90.68M
116.92%125.11M
49.54%108.66M
58.04%99.68M
0.98%53.72M
58.25%57.68M
67.72%72.67M
15.41%63.08M
-18.63%53.20M
-58.42%36.45M
-50.51%43.33M
-40.91%54.66M
-25.32%65.38M
12.86%87.66M
29.63%87.55M
Total assets
132.81%1.53B
84.05%1.06B
74.91%1.03B
75.12%702.61M
75.90%656.69M
75.28%577.69M
77.01%586.01M
81.66%401.21M
89.16%373.32M
70.27%329.59M
51.94%331.07M
-12.24%220.85M
-34.87%197.36M
-49.01%193.57M
-46.82%217.89M
-47.72%251.67M
-44.77%303.03M
-39.32%379.63M
49.60%409.69M
63.40%481.40M
Total liabilities
125.49%945.71M
16.86%415.23M
6.08%417.81M
90.57%426.18M
96.70%419.40M
110.15%355.33M
136.84%393.86M
23.97%223.64M
25.48%213.21M
25.26%169.09M
41.64%166.30M
47.11%180.40M
28.11%169.93M
-5.26%134.99M
19.60%117.41M
24.79%122.63M
28.26%132.64M
34.04%142.48M
-4.87%98.17M
-2.12%98.27M
Total equity
145.75%583.13M
191.42%648.02M
216.00%607.22M
55.68%276.43M
48.20%237.29M
38.54%222.36M
16.62%192.16M
338.95%177.57M
483.64%160.11M
173.95%160.50M
63.98%164.77M
-68.65%40.45M
-83.90%27.43M
-75.30%58.59M
-67.74%100.48M
-66.32%129.03M
-61.74%170.39M
-54.34%237.15M
82.54%311.52M
97.26%383.13M
Cash Flow Statement
Net operating income
37.68%-17.89M
176.67%19.66M
-89.70%-23.15M
34.32%7.44M
-249.88%-28.71M
-94.10%-25.64M
-114.58%-12.21M
113.18%5.54M
86.30%-8.21M
44.66%-13.21M
342.66%83.70M
14.48%-42.01M
12.79%-59.90M
72.53%-23.87M
48.67%-34.49M
18.37%-49.12M
15.57%-68.69M
-67.05%-86.91M
-18.87%-67.20M
-37.27%-60.17M
Net investment
23.74%-9.86M
-199.05%-15.64M
596.71%46.36M
-326.18%-3.99M
-39.75%-12.93M
135.28%15.79M
69.12%-9.33M
-94.21%1.77M
-50.05%-9.26M
-375.09%-44.76M
-911.00%-30.23M
193.87%30.50M
85.88%-6.17M
394.80%16.27M
-373.85%-2.99M
519.35%10.38M
-8396.30%-43.67M
106.31%3.29M
-104.23%-631.00K
-122.09%-2.48M
Net financing
6504.93%390.83M
117.42%1.06M
-158.19%-78.24M
-4872.59%-6.44M
-61120.00%-6.10M
-607100.00%-6.07M
31836.82%134.45M
-99.71%135.00K
-99.96%10.00K
-102.04%-1.00K
53.09%421.00K
34749.63%47.05M
3069.18%25.24M
-99.91%49.00K
103.74%275.00K
101.88%135.00K
-1445.45%-850.00K
-86.12%56.00M
-120.87%-7.36M
-102.97%-7.16M

FAQs

What is the total revenue of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its total revenue reached 616.29M, with a year-on-year change of 329.00M.

What are the current assets of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its current assets were 630.76M, with a year-on-year change of 11.37.

What are the total assets of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its total assets of TG Therapeutics Inc were 1.06B, with a year-on-year change of 84.05.

What are the total liabilities of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its total liabilities of TG Therapeutics Inc were 415.23M, with a year-on-year change of 16.86.

What is the total equity of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its total equity of TG Therapeutics Inc was 648.02M, with a year-on-year change of 191.42.

What is the net operating income of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its net operating income of TG Therapeutics Inc was 123.32M, with a year-on-year change of 194.13.

What is the net investment of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its net investment of TG Therapeutics Inc was 13.80M, with a year-on-year change of 1431.95.

What is the net financing of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its net financing of TG Therapeutics Inc was -89.73M, with a year-on-year change of -169.81.

What is the Earnings Per Share (EPS) of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 3.10, with a year-on-year change of 1825.67.

What is the net income of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its net income was 447.18M, with a year-on-year change of 1812.41.

What is the net margin of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its net profit margin was 72.56, with a year-on-year change of 920.94.

What is the gross margin of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its gross margin was 83.66, with a year-on-year change of -5.26.

What is the debt-to-asset ratio of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 23.10, with a year-on-year change of -45.40.

What is the Return on Equity (ROE) of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 102.75, with a year-on-year change of 741.23.

What is the Return on Assets (ROA) of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 54.50, with a year-on-year change of 957.37.

What is the operating profit of TG Therapeutics Inc?

According to TG Therapeutics Inc's FY2025 earnings report, its operating profit was 123.32M, with a year-on-year change of 194.13.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy